Fatal Interstitial Lung Disease after Addition of Sorafenib to a Patient with Lung Adenocarcinoma Who Had Failed to Improve with Erlotinib Alone

Interstitial lung disease (ILD) induced by epidermal growth factor receptor tyrosine kinase inhibitors has been extensively documented with decreasing incidence after appropriate patient selection due to increasing awareness over the years. However, ILD induced by sorafenib was mentioned with lower...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Guan, Yin, Meng, Jing, Zhao, Hong, Hu, Yi, Yan, Xiang, Zhao, Shao-Hong, Jiao, Shun-Chang
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger AG 2014
Témata:
Published online: April, 2014
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4036133/
https://ncbi.nlm.nih.gov/pubmed/24926256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000362402
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky